How much improvement in survival with newer agents?

[thesauce]

Advertisement - Members don't see this ad

Hi guys,

I was wondering if anyone has run across a table (or other visual) which lays out the improvement in survival for NSCLC provided by some of the newer agents (immunotherapies, etc)? I just want to put the benefit of early palliative referrals in perspective for a presentation that I'm giving.

Something like this but with a few more drugs listed: http://jtd.amegroups.com/article/viewFile/106/188/698

 

[gutonc]

No, I think it's still too early for that....

But I think the benefit of early palliative care referral still holds.

 

[thesauce]

No, I think it's still too early for that....

But I think the benefit of early palliative care referral still holds.

Alright. Thanks, gutonc!

 

[abish]

Nothing has changed after this in NSCLC.